• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 1912997
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/31/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation has determined that lower than expected thyroid stimulating hormone (tsh) results were obtained from samples from multiple patients processed using three different lots of vitros immunodiagnostic products tsh reagent on a vitros 5600 integrated system.The results were considered lower than expected when compared to tsh results obtained from a non-vitros roche cobas system.The magnitude of bias of the vitros tsh results meets potential health and safety criteria and the results are reportable.The assignable cause for the lower than expected vitros tsh results is a sample related issue likely due to the presence of biotin.It was confirmed that several samples that produced lower than expected vitros tsh results were from patients that were taking supplements containing biotin.In addition, a second correlation using samples from 20 random patients yielded results that were concordant between the vitros and roche methods for all 20 samples.In july 2018, ortho issued a customer communication (b)(4) to alert customers that biased results may occur for specific vitros integrated products (microwell assays) at biotin concentrations which are lower than indicated in the current instructions for use (ifu).Based on historical quality control results, a vitros tsh reagent performance issue is not a likely contributor to the event.There was no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event.Vitros tsh within run precision testing results from the vitros 5600 system were within ortho acceptable guidelines.However, the precision testing did not occur around the time of the initial event.Therefore, an instrument related issue cannot be completely ruled out as a contributing factor of the event.In addition, pre-analytical sample processing could be entirely ruled out as a contributing factor, as it is unknown if the sample collection device manufacturer¿s recommendation for sample centrifugation was being followed.Improper pre-analytical sample handling could have contributed to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.Per a medical consult with an ortho medical safety officer: patients may experience sub-optimally controlled thyroid disease or potentially the side effects of changed medication or increase dose of medicine.However, patients who are under treatment of thyroid diseases, thyroid function tests are often ordered regularly to monitor treatment effects.Serious injuries due to altered thyroid medication is unlikely.Email address for contact office in field is (b)(4).
 
Event Description
A customer obtained lower than expected thyroid stimulating hormone (tsh) results from samples from multiple patients processed using three different lots of vitros immunodiagnostic products tsh reagent on a vitros 5600 integrated system.The results were considered lower than expected when compared to tsh results obtained from a non-vitros roche cobas system.The magnitude of bias of the vitros tsh results meets potential health and safety criteria and the results are reportable.Lot 6430: patient 3 vitros tsh result of <0.015* miu/l vs the expected result of 1.3 miu/l.Patient 4 vitros tsh result of 0.99* miu/l vs the expected result of 1.6 miu/l.Lot 6470: patient 5 vitros tsh result of 0.09* miu/l vs the expected result of 0.31 miu/l.Patient 8 vitros tsh result of 0.15* miu/l vs the expected result of 0.31 miu/l.Patient 10 vitros tsh result of 2.37* miu/l vs the expected result of 5.9 miu/l.Lot 6480: patient 11 vitros tsh result of 0.036* miu/l vs the expected result of 1.1 miu/l patient 13 vitros tsh result of 0.014* miu/l vs the expected result of 1.1 miu/l biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected.The lower than expected vitros tsh patient sample results were reported from the laboratory.A physician later questioned the results, however, based on the lower than expected results thyroid medications had been altered for several patients.The physician did not provide any further specific details regarding the altered treatments or medications.Ortho has not been made aware of any allegation of patient harm as a result of this event.This report is number six of seven mdr¿s for this event.Seven 3500a forms are being submitted for this event as seven devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint number (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key11886491
MDR Text Key266241764
Report Number3007111389-2021-00075
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/01/2022
Device Catalogue Number1912997
Device Lot Number6480
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/28/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/25/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-